Bronchopulmonary Dysplasia Drug Market is witnessing steady global growth driven by the increasing incidence of premature births and the rising prevalence of neonatal respiratory disorders. Bronchopulmonary dysplasia (BPD), a chronic lung condition primarily affecting preterm infants, has become a significant concern in neonatal intensive care units (NICUs) worldwide. The growing awareness about early diagnosis and treatment, along with advancements in neonatal care, is fueling demand for effective drug therapies. Innovations in corticosteroids, bronchodilators, and anti-inflammatory drugs are improving treatment outcomes and reducing long-term complications. Additionally, increasing investments in pediatric healthcare and research initiatives are accelerating the development of targeted therapies for BPD. The expansion of healthcare infrastructure, especially in developing regions, is also contributing to market growth as access to specialized neonatal care improves.Related reports:
Endoscope Leak Tester Market
Iron Vitamin Gummies Market
Histone H3 Antibody Market
Peripherin Antibody Market
Plasmid Dna Cdmo Market
Calpeptin Market
Chromoblastomycosis Treatment Market
Angiopoietin 1 Receptor Market